The Trendlines Group, specializing in medical devices and agritech, plans to take its incubator model, IP knowledge to China
By David Shamah
The Times of Israel - February 19, 2015
Not a week goes by, it seems, without a large delegation of Chinese business people, investors and government officials visiting Israel to look for deals, start-ups and joint projects with businesses and universities. In a sense, the Israel-China business channel has become very crowded – overcrowded, some might say – as VCs and large corporations on both sides compete for the best deals.
But most of that action is taking place among top-tier organizations – companies and venture capital funds that invest in the largest projects and organizations, according to D. Todd Dollinger, Chairman and CEO of The Trendlines Group, an Israeli investment firm that specializes in early stage start-ups in the areas of medical devices and agricultural technology.